GFAP and Cognitive impairment: The administration of minocycline in 8-month-old 3xTg-AD mice was also shown to prevent cognitive deficits and to decrease insoluble Aβ and soluble fibrils via the reduction of inflammatory agents such as GFAP, TNF-α and IL-6 [79].